NEWS

Peptide News & Research

Fresh headlines from around the web and newly published peer reviewed abstracts from PubMed, automatically refreshed every day to keep you updated on the latest research, discoveries, and scientific discussions. Designed for educational and informational purposes only. Content is not intended to provide medical advice, diagnosis, treatment, or replace guidance from a qualified healthcare professional.

Peptide News & Research

Wegovy, weight loss and cardiovascular health: A closer look at how semaglutide protects the heart - Cardiovascular Business

Semaglutide and other GLP-1 drugs not linked to risk of degenerative eye disease in adults with type 2 diabetes - Medical Xpress

Semaglutide for Refractory Reactive Hypoglycaemia: A Case Report - Cureus

Study Finds No Statistical Link Between Use of Semaglutide and Other GLP-1 Drugs and Risk of Degenerative Eye Disease in Adults with Type 2 Diabetes - Johns Hopkins Medicine

FDA to review Amneal's, Adalvo's 2 ANDAs for generic tirzepatide autoinjector - Drug Store News

Phase 2 Trial Supports GLP-1 Therapy for Advanced Liver Disease - Technology Networks

The Experimental Weight-Loss Peptide Spreading Among Teens - Air Mail

From Ozempic to oat bars: Can peptide science cross into food? - BakeryAndSnacks.com

Compounded GLP-1s: Why doctors worry and the FDA is cracking down - Stanford Medicine

People Can Lose Their Zest for Life After Starting GLP-1s, Docs Warn - Gizmodo

SUMMIT: Benefits From Tirzepatide Similar By Sex in Patients With Obesity-Related HFpEF - American College of Cardiology

What Are Peptides? The Viral Health Trend, Explained - mentalfloss.com

Orforglipron vs. Tirzepatide: What Are the Major Differences? - GoodRx

‘Please don’t lose another pound!’: Ozempic is upending the wedding dress industry - The Guardian

India's Sun Pharma wins South Africa approval to launch generic Ozempic - Reuters

Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus? - Cureus

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization - Cureus

Sun Pharma’s generic semaglutide wins marketing approval in South Africa - ETPharma.com

Dr. Nirusha Kumaran Discusses the Future of Peptides: Regenerative Medicine, Longevity, and New Frontiers - Whoopsee

Why Semaglutide is an inflection point for India’s generics sector? - The Hindu

Study flags need to monitor frailty risks with GLP-1 drugs for older adults - Reuters

Peptides for injury recovery: medical miracle or medical risk? - FOX Carolina News

Holistic Lifestyle Changes Crucial for Effective GLP-1 Therapy - Drug Topics

The Precision Peptide Company Receives 20,000-Unit Production Run Of BPC-157 Transdermal Patches - marketscreener.com

The unapproved but very online weight-loss drug - Politico

The Precision Peptide Company Inc. Receives 20,000-Unit Production Run of BPC-157 Transdermal Patches - TMX Newsfile

Popular weight-loss drugs Ozempic and Wegovy may slow biological aging - ScienceDaily

Semaglutide dose may matter more than weight loss for heart health - News-Medical

FDA Accepts Sandoz Generic Tirzepatide Applications Amid Biosimilar Development Gap - Center for Biosimilars

Tirzepatide Costs, Insurance Coverage & Savings Tips - Forbes

Nearly one in 10 Britons use or want weight-loss medication - News-Medical

FDA staff question peptides backed by Kennedy ahead of advisory panel review - Post and Courier

Tirzepatide vs. Semaglutide: What You Should Know - Cleveland Clinic Health Essentials

Peptide Therapy Benefits | BioVitality Austin - Community Impact

Peptide therapy and longevity approach - fox5sandiego.com

Gray market peptides blur drug and supplement distinctions, raising health risks - Nutrition Insight

Wellness Peptides: What Influencers Aren’t Telling You About the Risks - Healthline

The male wellness guide to peptides - Financial Times

What's behind the push to make peptide therapies more readily available - NPR

Semaglutide vs. Tirzepatide vs. Orforglipron for Weight Loss - US News Health

Risk of pancreatic cancer associated with GLP-1 receptor agonist therapy - Nature

Peptides: What they are, potential benefits, and safety concerns - Harvard Health

What are peptides? And why am I hearing so much about them? - The Conversation

The peptide boom: why everyone's suddenly talking about BPC-157, its bold claims - and the hidden risks - mensfitness.co.uk

Evipedia expands evidence reviews to cover peptides - Longevity.Technology

Stronger than Ozempic. Not exactly legal. ‘Reta’ has entered the chat. - The Washington Post

Heal or Harm: Body Protective Compound-157 in the Gray Zone - Pharmacy Times

US FDA accepts Sandoz applications for proposed in-house development of generic tirzepatide GLP-1s - Sandoz

GLP-1s 101: What the science says about weight loss, side effects, safety - Stanford Medicine

Longevity, wellness physicians named to panel advising FDA on peptides - STAT

FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr. - PBS

FDA to discuss easing restrictions on peptides despite safety concerns - The Guardian

GLP-1 drug tirzepatide may boost calorie-burning brown fat - The Hill

Peptides Aren't Actually Legal Yet, Here's What Has to Happen Before RFK Jr.'s 2026 Plan Takes Effect - Raleigh News & Observer

Rugiet Sets a New Standard for Performance Medicine with Launch of Physician-Prescribed Peptide and Longevity Therapies - Business Wire

Retatrutide, the newest weight-loss drug, helped people lose 30% of body weight, on par with weight-loss surgery - UCHealth

Multicomponent Stapling of Glucagon-Like Peptide-1 Enables Receptor-Guided PROTAC Delivery - Wiley Online Library

Croatian researchers thrust into limelight as their 1990s’ peptide discovery goes mainstream in the US - Chemistry World

Whole-Body Spatial Intelligence Beyond Weight-loss: nference Advances Cardiometabolism Moat for Precision Peptide Medicines and Healthy Longevity - PR Newswire

Peptide Therapy for Weight Loss: Separating Clinical Promise From Social Media Hype - Pharmacy Times

Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss market - Reuters

This weight-loss drug hasn't been approved by the FDA. Doctors are prescribing it anyway. - CBS News

Triple-action diabetes jab shown to reduce blood sugar and body weight - The Guardian

Retatrutide Data Show Dramatic Weight Loss, Other Benefits - Medscape

Lilly shares safety, tolerability data on its next-gen obesity drug | STAT - STAT

The Emerging Role of Oral Peptide Therapeutics in Dermatology - Dermatology Times

These 6 Lifestyle Habits Are More Effective Than the Peptide Craze, Experts Say - TODAY.com

New powerful GLP-1 drugs drop a lot of weight fast. How does that affect health? - Scientific American

Weight Loss: Lilly's New Drug Helped People Lose Up to 85 Pounds - Healthline

Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial - Eli Lilly and Company

From GLP-1s to Insulin: What to Know About Peptides - NewYork-Presbyterian

Peptide therapy finds a home in San Antonio's wellness market - San Antonio Report

Peptides Explained: How they’re changing health and wellness - WFLA

Not just GLP-1: Peptide-drug conjugate hits 5 obesity targets - Chemical & Engineering News

The Amino-zing World of Peptide Regulation - ArentFox Schiff

What doctors want patients to know about injectable peptides - American Medical Association | AMA

People are injecting peptides for weight loss and longevity. Doctors are alarmed at the side effects. - Business Insider

The beauty industry welcomes a flood of new peptide products as 'peptide therapy' trends online - glossy.co